Literature DB >> 8480642

Clinical significance of morphologic classification of coronary arterial segmental stenosis due to Kawasaki disease.

A Suzuki1, T Kamiya, Y Ono, Y Kinoshita, S Kawamura, K Kimura.   

Abstract

Coronary arteriograms obtained in 1,392 patients from a cohort of 4,562 with Kawasaki disease showed 395 to have coronary arterial lesions. The specific lesions, known as segmental stenoses, were observed in 62 patients, involving 68 coronary arterial branches. The lesions involved the right coronary artery in 56 cases (14.2% of the group with arterial lesions) and the left coronary artery in the other 12 (3% of the overall group with arterial lesions). Three morphologic variations were observed. Braid-like lesions accounted for 15 lesions, involving the right coronary artery and occurring < 2 years after the onset of Kawasaki disease. Bridging vessels were observed in 40 of 68 arterial lesions, 30 of which involved the right coronary artery. Of these bridging vessels, 86% were present within 4 years of onset of the disease. Pericoronary communications were observed in the remaining 13 of 68 lesions, 11 involving the right coronary artery and appearing at variable intervals, but usually significantly later than the other lesions. Myocardial ischemia was found at the first study in 60% of braid-like lesions, but in only 29% of the lesions at follow-up studies. Of bridging vessels or pericoronary communications, 95 and 77%, respectively, were found to have produced ischemia in the initial study, which persisted in 78 and 77%, respectively. There are 3 different mechanisms involved in the formation of segmental stenosis, with different prognoses for the clinical course of myocardial ischemia.

Entities:  

Mesh:

Year:  1993        PMID: 8480642     DOI: 10.1016/0002-9149(93)90641-o

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Follow-up assessment of the collateral circulation in patients with Kawasaki disease who underwent dipyridamole stress technetium-99m tetrofosmin scintigraphy.

Authors:  T Fukuda; M Ishibashi; T Shinohara; T Miyake; T Kudoh; T Saga
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

2.  In vivo visualization of braid-like appearance in Kawasaki disease: insights from multi-modality imaging.

Authors:  Hiroki Nakano; Yu Kataoka; Satoshi Yasuda
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-30       Impact factor: 2.357

3.  Collateral vessels assessed by myocardial contrast echocardiography in patients with coronary artery lesions after Kawasaki disease.

Authors:  Y Kinoshita; A Suzuki; T Nakajima; Y Ono; Y Arakaki; T Kamiya
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

4.  Accelerated thrombotic occlusion of a medium-sized coronary aneurysm in Kawasaki disease by the inhibitory effect of ibuprofen on aspirin.

Authors:  Sejung Sohn; Kihwan Kwon
Journal:  Pediatr Cardiol       Date:  2007-10-10       Impact factor: 1.655

5.  Importance of evaluation of the right coronary artery by two-dimensional echocardiography in patients after Kawasaki disease: a right parasternal approach.

Authors:  Wataru Tamaki; Etsuko Tsuda; Igarashi Takehiro; Norio Tanaka; Mikiya Fujieda
Journal:  Heart Vessels       Date:  2014-02-09       Impact factor: 2.037

6.  Myocardial contrast echocardiography of coronary artery lesions due to Kawasaki disease.

Authors:  Y Kinoshita; A Suzuki; T Nakajima; Y Ono; Y Arakaki; T Kamiya; S Beppu
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

7.  Changes in coronary perfusion after occlusion of coronary arteries in Kawasaki disease.

Authors:  Ji Hee Kwak; Jinyoung Song; I-Seok Kang; June Huh; Heung-Jae Lee
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

Review 8.  Computed tomography coronary angiography is the way forward for evaluation of children with Kawasaki disease.

Authors:  Manphool Singhal; Pankaj Gupta; Surjit Singh; Niranjan Khandelwal
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.